약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 3.

Table. 3.

Cost and utilization trends of donepezil by provider type

Proportion of cost (1,000 USD) Proportion of utilization (1,000 DDD)
2016 2017 2018 2019 2020 CAGR1) 2016 2017 2018 2019 2020 CAGR
Nationwide cost 177,075 199,446 225,269 248,178 253,104 9.3% 120,180 136,791 154,665 170,472 182,904 11.1%
Teritiary hospital 1.4% 1.3% 1.2% 1.3% 1.3% 7.1% 2.1% 1.7% 1.4% 1.5% 1.4% 1.0%
General hospital 4.1% 3.8% 3.6% 3.3% 3.2% 3.1% 5.1% 4.9% 4.8% 4.3% 4.0% 4.2%
Hospital 4.0% 3.3% 3.1% 2.8% 2.6% -2.3% 5.0% 4.1% 4.0% 3.7% 3.3% 0.3%
Long-term care hospital 18.8% 18.5% 17.3% 14.7% 10.0% -6.7% 21.1% 21.3% 20.5% 18.5% 17.4% 5.9%
Clinic 1.8% 1.8% 1.8% 2.1% 2.2% 15.6% 3.4% 3.5% 3.6% 3.8% 3.9% 15.4%
Pharmacy 70.0% 71.4% 72.9% 75.8% 80.7% 13.3% 63.3% 64.3% 65.7% 68.2% 69.8% 13.8%
etc. 0.1% 0.1% 0.1% 0.1% 0.1% 20.3% 0.1% 0.1% 0.1% 0.1 0.1 14.6%

1)CAGR (Compound Annual Growth Rate) formula which means average growth rate of value (V) during time in years (t) calculated by a formula; (Vfinal/Vbegin)^(1/t) – 1.

Yakhak Hoeji 2022;66:58-65 https://doi.org/10.17480/psk.2022.66.2.58
© 2022 Yakhak Hoeji